Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Follow us on Google+Follow us on TwitterFind us on LinkedInFind Us on FacebookSubscribe to our RSS FeedsSubscribe to our YouTube ChannelFind us on RebelMouse

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for September 17, 2013 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



Transvaginal Mesh Lawsuit Update: Rottenstein Law Group LLP Comments on JAMA Study That Shows Mesh Less Effective at Pelvic Organ Prolapse Treatment

The firm is currently offering transvaginal mesh lawsuit evaluations to women who allege that they sustained injuries from transvaginal mesh implants
 
x-small text small text medium text large text

  • <strong>The firm is currently offering transvaginal mesh lawsuit evaluations to women who allege that they sustained injuries from transvaginal mesh implants.</strong>

YouTube Video

The firm is currently offering transvaginal mesh lawsuit evaluations to women who allege that they sustained injuries from transvaginal mesh implants.

Erosion, which is cited in the study, is the most common side effect alleged.

    NEW YORK, NY, September 17, 2013 /24-7PressRelease/ -- Transvaginal mesh is less effective than other surgical procedures used to treat pelvic organ prolapse, according to a study published on Sept. 11, 2013, in The Journal of the American Medical Association. The Rottenstein Law Group LLP, a vaginal mesh law firm, encourages those interested in more information on surgical mesh lawsuits and side effects to visit its Vaginal Mesh Lawsuits Center.

Surgical mesh eroded through the vaginal wall about 11 percent of the time over the course of the seven year research study, and "was less effective than desired as a standard criterion procedure for pelvic organ prolapse," according to the JAMA.*

"We hear from several women daily who believe they are suffering from the alleged side effects of transvaginal mesh products manufactured by a handful of companies," said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. "Erosion, which is cited in the study, is the most common side effect alleged."

Women are filing vaginal mesh lawsuits alleging they suffered adverse side effects such as pain, discomfort and difficulty having sex, in addition to vaginal erosion, according to court documents.**

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged side effects of their transvaginal mesh implants to visit the firm's FAQ page at www.vaginalmeshlawsuitscenter.com/the-most-frequently-asked-tvm-questions/ for quick answers to questions about mesh harms and lawsuits.

*jama.jamanetwork.com/article.aspx?articleid=1737031

**C.R. Bard, American Medical Systems, Boston Scientific, Ethicon, Coloplast and Cook Medical; MDLs-2187, 2325, 2326, 2327, 2387 and 2440; U.S. District Court for the Southern District of West Virginia. http://www.wvsd.uscourts.gov/MDL/amsinc/pdfs/PTO_80.pdf

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com



---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Read more Press Releases from Rochelle Rottenstein:


Contact Information:
Rochelle Rottenstein
Rottenstein Law Group LLP

New York, NY
USA
Voice: 212-933-9500
E-Mail: Email us Here
Website: Visit Our Website
Follow Us:
 Find Us on Facebook Follow Us on Google+ Follow Us on Twitter
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.